Track topics on Twitter Track topics that are important to you
Sinovac Biotech is one of 49 publicly-traded companies in the "Biopharmaceuticals" industry, but how does it weigh in compared to its competitors? We will compare Sinovac Biotech to related companies based on the strength of its analyst recommendations, valuation, institutional ownership, dividends, profitability, earnings and risk. As a group, "Biopharmaceuticals" companies have a potential upside of 9.61%.
Original Article: Reviewing Sinovac Biotech (SVA) and The CompetitionNEXT ARTICLE
Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...
BioPortfolio lists over 550 biotechnology products - please open http://www.bioportfolio.com/channels?category_id=5 Direct topic pages: Actos Advair Biopharmaceuticals Biosimilars Biotherapeutics GMO Crops Lipitor ...